MedTrace Logo

The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function

NCT07431788 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-03-03

No results posted yet for this study

Summary

This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.

Conditions

  • Leiomyoma (Uterine Fibroids)
  • Adenomyoma of Uterus
  • Uterine Bleeding

Interventions

PROCEDURE

Uterine Manipulator

Use of a uterine manipulator during total abdominal hysterectomy.

PROCEDURE

Conventional Abdominal Hysterectomy

Total abdominal hysterectomy without uterine manipulator.

Sponsors & Collaborators

  • Erkan Gol

    lead OTHER_GOV

Principal Investigators

  • Erkan Göl, MD · University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-02
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07431788 on ClinicalTrials.gov